CellType: human melanoma cells  
AssayName: quantitative (phospho)-proteomics  
Compound: dabrafenib  
Compound: trametinib  
Compound: SCH772984  
CellLine: A375 (ATCC, CRL-1619) cells  
SampleTreatment: serum starved for 24 hours  
Time: 24 hours  
SampleTreatment: serum was then added back to the cells for 24 hours  
Compound: Dabrafenib (Selleckchem, S2807)  
Compound: trametinib (Selleckchem, S2673)  
Compound: SCH772984 (Selleckchem, S7101)  
ConcentrationOfCompound: 500 μM  
ConcentrationOfCompound: 100 μM  
Temperature: −80 °C  
Time: 30 minutes  
MaterialType: modified RIPA buffer with protease/phosphatase inhibitors  
ReductionReagent: 1 mM Dithiothritol  
AlkylationReagent: Chloroacetamide  
CleavageAgent: Lys-C protease (Wako Chemical Corporation, 129-02541)  
CleavageAgent: trypsin (Sigma-Aldrich, T6567)  
FractionationMethod: strong cation exchange chromatography  
Separation: strong cation exchange chromatography (SCX)  
EnrichmentMethod: titanium dioxide beads  
Instrument: Q-Exactive Orbitrap mass spectrometer  
FlowRateChromatogram: 250 nl/min  
GradientTime: 250 minute gradient  
GradientTime: 240 minutes  
Instrument: ThermoFisher Scientific Q Exactive mass spectrometer  
CellLine: HEK293 cells  
MaterialType: magnetic M2 anti-FLAG beads (Sigma-Aldrich)